Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业) is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration (SFDA) to manufacture and sell over 210 other products.
Read more about Simcere Pharmaceutical: Acquisitions, Products, Endu, Bicun, Zailin, Yingtaiqing, Other Branded Generics, See Also